From national to international collaboration in GTD: hurdles and possibilities

被引:4
作者
Golfier, Francois [1 ]
Seckl, Michael J. [2 ]
机构
[1] Lyon1 Claude Bernard Univ, Lyon Sud Univ Hosp, French Trophoblast Dis Reference Ctr, Dept Obstet & Gynecol, Lyon, France
[2] Imperial Coll London, Charing Cross Hosp Campus, Dept Med Oncol, London W6 8RF, England
关键词
gestational trophoblastic disease; national; international; collaboration; choriocarcinoma; GESTATIONAL TROPHOBLASTIC DISEASE; RESISTANCE; DIAGNOSIS; NEOPLASIA; OUTCOMES; TUMORS;
D O I
10.1159/000534321
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background : Today most women with gestational trophoblastic disease (GTD) can expect to be cured particularly if they live in middle to high income countries with access to GTD centres. In contrast, countries lacking organized GTD care achieve lower survival rates.Objectives : To review and consider some of the successes and areas for improvement in GTD care that have been achieved through national and international collaborations.Methods : The authors searched PubMed and used their own knowledge of working nationally and internationally in GTD to write this reviewConclusions : The establishment of expert centres and national systems for managing GTD is associated with the best disease outcomes. National and in particular international collaboration is most likely to result in further optimisation of management protocols and outcomes.Outlook : It remains crucial for countries lacking GTD centres to try and establish such facilities with support from national agencies and international expert societies.
引用
收藏
页码:254 / 258
页数:5
相关论文
共 36 条
[1]   Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia [J].
Agarwal, R. ;
Harding, V. ;
Short, D. ;
Fisher, R. A. ;
Sebire, N. J. ;
Harvey, R. ;
Patel, D. ;
Savage, P. M. ;
Lim, A. K. P. ;
Seckl, M. J. .
BRITISH JOURNAL OF CANCER, 2012, 106 (06) :1089-1094
[2]   EMA/CO for High-Risk Gestational Trophoblastic Neoplasia: Good Outcomes With Induction Low-Dose Etoposide-Cisplatin and Genetic Analysis [J].
Alifrangis, Constantine ;
Agarwal, Roshan ;
Short, Delia ;
Fisher, Rosemary A. ;
Sebire, Neil J. ;
Harvey, Richard ;
Savage, Philip M. ;
Seckl, Michael J. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (02) :280-286
[3]   European Reference Network for rare adult solid cancers, statement and integration to health care systems of member states: a position paper of the ERN EURACAN [J].
Blay, J. -Y. ;
Casali, P. ;
Bouvier, C. ;
Dehais, C. ;
Galloway, I. ;
Gietema, J. ;
Halamkova, J. ;
Hindi, N. ;
Idbaih, A. ;
Kinloch, E. ;
Klumpen, H. -J. ;
Kolarova, T. ;
Kopeckova, K. ;
Lovey, J. ;
Magalhaes, M. ;
Oselin, K. ;
Piperno-Neumann, S. ;
Ravnsbaek, A. ;
Rogasik, M. ;
Safwat, A. ;
Scheipl, S. ;
Seckl, M. ;
Taylor, J. ;
Temnyk, M. ;
Trama, A. ;
Urbonas, M. ;
Wartenberg, M. ;
Weinman, A. .
ESMO OPEN, 2021, 6 (04)
[4]  
Bolze, 2015, AM J OBSTET GYNECOL
[5]   Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study [J].
Braga, Antonio ;
Paiva, Gabriela ;
Ghorani, Ehsan ;
Freitas, Fernanda ;
Velarde, Luis Guillermo Coca ;
Kaur, Baljeet ;
Unsworth, Nick ;
Lozano-Kuehne, Jingky ;
Esteves, Ana Paula Vieira dos Santos ;
Filho, Jorge Rezende ;
Amim Jr, Joffre ;
Aguiar, Xianne ;
Sarwar, Naveed ;
Elias, Kevin M. ;
Horowitz, Neil S. ;
Berkowitz, Ross S. ;
Seckl, Michael J. .
LANCET ONCOLOGY, 2021, 22 (08) :1188-1198
[6]   Camrelizumab plus apatinib in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia (CAP 01): a single-arm, open-label, phase 2 trial [J].
Cheng, Hongyan ;
Zong, Liju ;
Kong, Yujia ;
Wang, Xiaoyu ;
Gu, Yu ;
Cang, Wei ;
Zhao, Jun ;
Wan, Xirun ;
Yang, Junjun ;
Xiang, Yang .
LANCET ONCOLOGY, 2021, 22 (11) :1609-1617
[7]   Successful treatment of metastatic refractory gestational choriocarcinoma with pembrolizumab: A case for immune checkpoint salvage therapy in trophoblastic tumors [J].
Clair, Kiran H. ;
Gallegos, Nicolas ;
Bristow, Robert E. .
GYNECOLOGIC ONCOLOGY REPORTS, 2020, 34
[8]   Transcriptomic Characterization of Postmolar Gestational Choriocarcinoma [J].
Collet, Constance ;
Lopez, Jonathan ;
Battail, Christophe ;
Allias, Fabienne ;
Devouassoux-Shisheboran, Mojgan ;
Patrier, Sophie ;
Lemaitre, Nicolas ;
Hajri, Touria ;
Massardier, Jerome ;
You, Benoit ;
Mallet, Francois ;
Golfier, Francois ;
Alfaidy, Nadia ;
Bolze, Pierre-Adrien .
BIOMEDICINES, 2021, 9 (10)
[9]   Outcome of First-Line Hysterectomy for Gestational Trophoblastic Neoplasia in Patients No Longer Wishing to Conceive and Considered With Isolated Lung Metastases: A Series of 30 Patients [J].
Dabi, Yohann ;
Hajri, Touria ;
Massardier, Jerome ;
Mathe, Melodie ;
You, Benoit ;
Lotz, Jean-Pierre ;
Patrier, Sophie ;
Khawajkie, Yassemine ;
Schott, Anne Marie ;
Golfier, Francois ;
Bolze, Pierre-Adrien .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (09) :1766-1771
[10]   Can the FIGO 2000 scoring system for gestational trophoblastic neoplasia be simplified? A new retrospective analysis from a nationwide dataset [J].
Eysbouts, Y. K. ;
Ottevanger, P. B. ;
Massuger, L. F. A. G. ;
IntHout, J. ;
Short, D. ;
Harvey, R. ;
Kaur, B. ;
Sebire, N. J. ;
Sarwar, N. ;
Sweep, F. C. G. J. ;
Seckl, M. J. .
ANNALS OF ONCOLOGY, 2017, 28 (08) :1856-1861